Giant Biogene Holding Co. Ltd. ( (HK:2367) ) just unveiled an announcement.
Giant Biogene Holding Co., Ltd. announced a placing and top-up subscription agreement involving 35 million shares at HK$66.65 per share, expected to raise approximately HK$2,294 million in net proceeds. The funds will be used to enhance the company’s financial strength, market competitiveness, and shareholder base, supporting long-term sustainable development and liquidity.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd. is an exempted company incorporated in the Cayman Islands, operating primarily in the biotechnology industry. The company is involved in the development and marketing of biogene products, with a focus on expanding its brand, marketing efforts, and research and development investments.
YTD Price Performance: 52.71%
Average Trading Volume: 4,018,618
Technical Sentiment Signal: Sell
Current Market Cap: HK$77.71B
Find detailed analytics on 2367 stock on TipRanks’ Stock Analysis page.